Free Trial

SPDR S&P Biotech ETF (XBI) News Today

SPDR S&P Biotech ETF logo
$96.24 +1.94 (+2.06%)
(As of 11/22/2024 ET)
Stethoscope, bunch dollars , concept expensive medicine
Is Biotech’s Bull Run Over? Examining Election Impacts (XBI)
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.
Digital interface with hologram of dna and hud with icons of lungs, pills, thermometer, syringe, emergency call, diagnostics, pie diagram. Concept of future technologies in health care. 3d rendering — Photo
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now (XBI)
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.
XBI June 7th Options Begin Trading
Some Bubbles Are Starting To Pop
Novartis Looks To Get Back On Track With Q1 Earnings
2 Top Biotech Buyout Candidates
3 Biotech Stocks to Buy on the Dip: March 2024
3 Biotech ETFs Overdue for a Bounce
Heard on the Street Recap: Zooming Up
Spdr S&P Biotech Etf
XBI ETF Stock Price History
SPDR S&P Biotech ETF (XBI)
Novavax in 2024: What to expect?
SPDR S&P Biotech ETF stock logo
Private Wealth Advisors LLC Acquires Shares of 56,942 SPDR S&P Biotech ETF (NYSEARCA:XBI)
Private Wealth Advisors LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 56,942 shares of the exchange tra
It’s Biotech Stocks’ Time to Shine
Biotech Stocks Rally After $10.1 Billion ImmunoGen Buyout
How to play Disney options ahead of earnings
With This Rally, Rocket Just Might Take Off
3 Nasdaq Biotechs With New 52-Week Highs
September Puts Options Trades Update #4
6 Healthcare Stocks Analysts Still Like
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
Get SPDR S&P Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

917 Trades… Zero Losses? (Ad)

As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today

XBI Media Mentions By Week

XBI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XBI
News Sentiment

0.57

0.57

Average

News Sentiment

XBI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XBI Articles
This Week

3

0

XBI Articles
Average Week

Get SPDR S&P Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEARCA:XBI) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners